NCT01290939 2021-02-15
Bevacizumab and Lomustine for Recurrent GBM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
European Organisation for Research and Treatment of Cancer - EORTC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins